Identification of micronuclei in the lymphocytes of the type 2 diabetes mellitus according to the period of diagnosis as a biomarker

Authors

Harem Othman Smail, Department of Biology, Faculty of Science and Health, Koya University, Koya KOY45, Kurdistan, IraqFollow

How to Cite This Article

Smail, Harem Othman (2023) "Identification of micronuclei in the lymphocytes of the type 2 diabetes mellitus according to the period of diagnosis as a biomarker," Polytechnic Journal: Vol. 13: Iss. 2, Article 4.
DOI: https://doi.org/10.59341/2707-7799.1720

Document Type

Original Article

Abstract

Micronuclei in lymphocytes can indicate DNA damage or chromosomal instability. This study aimed to compare the Micronuclei to the different period diagnoses of type 2 diabetes mellitus. Four groups were created out of 140 people: type 2 diabetes mellitus 1 year, type 2 diabetes mellitus 1 to 3 years, type 2 diabetes mellitus 3 to 5 years, and control. Each group had 35 participants. The blood sample taken from the individuals was put on a slide, fixed with 5% geimsa solution or Leishman stains, and examined under a microscope. Micronuclei scoring was completed afterwards. Additionally, p ≤ 0.05 was utilized to determine the significance of the one-way analysis of variance (ANOVA) and Pearson correlation coefficient. The mean score of the micronuclei observed in group type 2 diabetes mellitus 1 year, type 2 diabetes mellitus 1 to 3 years, type 2 diabetes mellitus 3 to 5 years, and control. Were 0.2857, 0.6571, 0.7714, and 0.1143, respectively, type 2 diabetes mellitus 3 to 5 years showed significantly greater damage than the other three groups. Increased micronuclei frequency in type 2 diabetes mellitus patients according to the time since diagnosis may be associated with the aetiology and be regarded as an important biomarker of genotoxic damage, or DNA damage, in the disease's T2DM 1 to 3 years and third to fifth years.

Accept Date

27/09/2023

References

[1] Shettigar SKG, Shailaja C, Kulkarni RK. Elevated micronuclei frequency in type 2 diabetes with high glycosylated hemoglobin. Diabetes Res Clin Pract [Internet] 2012;95(2): 246e50. https://doi.org/10.1016/j.diabres.2011.10.025.

[2] Zúniga-Gonz ~ alez GM, Mart ínez-Sanchez JO, Zamora- Perez AL, Gallegos-Arreola MP, Torres-Mendoza BM, Gutierrez-Sevilla JE, et al. Micronuclei analysis in mice peripheral blood exposed to polarized polychromatic noncoherent light (Bioptron® Light). J Photochem Photobiol, A 2023;13(January). https://doi.org/10.1016/j.jpap.2023.100164.

[3] Fenech M, Knasmueller S, Knudsen LE, Kirsch-Volders M, Deo P, Franzke B, et al. Micronuclei and Disease special issue: aims, scope, and synthesis of outcomes. Mutat Res - Rev Mutat Res [Internet] 2021;788:108384. https://doi.org/ 10.1016/j.mrrev.2021.108384.

[4] Pongsavee M. Effect of sodium benzoate preservative on micronucleus induction, chromosome break, and Ala40Thr superoxide dismutase gene mutation in lymphocytes. BioMed Res Int 2015;2015. https://doi.org/10.1155/2015/103512.

[5] Lulla DS, Mali DA, AashwiinMiglani D, VidyaDodwad D, SachinMangalekar D, SandeepPatil D. Comparative evaluation of genotoxic effect in subjects with chronic periodontitis with and without type 2 diabetes mellitus. RGUHS J Dent Sci 2019;11(1):29e36. https://doi.org/10.26715/rjds.11_1_7.

[6] Smail H. Micronucleus test in epithelial cells from oral cavity in Koya University student smokers and non- smokers. Researchgate [Internet] 2021;(2):47e54. http://www.jemb.bio. uaic.ro/index.php/jemb/article/view/45.

[7] Franke SIR, Müller LL, Santos MC, Fishborn A, Hermes L, Molz P, et al. Vitamin C intake reduces the cytotoxicity associated with hyperglycemia in prediabetes and type 2 diabetes. BioMed Res Int 2013;2013. https://doi.org/10.1155/ 2013/896536.

[8] Surekha Ramrao R, Anubha R, Padmaja J, Trupti S. Assessment of cytogenic damage in chronic periodontitis and type 2 diabetes mellitus subjects through micronucleus test. Saudi J Oral Sci 2016;3(2):75. https://doi.org/10.4103/1658-6816.18807.

[9] Pappuswamy M, Rajesh N, Maria Philip A. Analysis of chromosomal aberrations and micronuclei in type 2 diabetes mellitus patients. Asian Pacific J Cancer Biol 2020;5(1):15e8. https://doi.org/10.31557/APJCB.2020.5.1.15-18.

[10] Palazzo RP, Bagatini PB, Schefer PB, de Andrade FM, Maluf SW. Genomic instability in patients with type 2 diabetes mellitus on hemodialysis. Rev Bras Hematol Hemoter 2012;34(1):31e5. https://doi.org/10.5581/1516-8484.20120011.

[11] Martínez-Perez LM, Cerda-Flores RM, Gallegos- Cabriales EC, Davila-Rodr íguez MI, Ibarra-Costilla E, Cortes-Guti errez EI. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus. Prague Med Rep 2007;108(3): 248e55. PMID: 18399062.

[12] Singh Ashwin, JayasabarinathanM, Jeevamani S. Identification ofmicronucleusin buccalmucosa of type-2 diabetic patients: an early diagnostic marker. Int J Anat Res 2016;4(2):2412e5. https://doi.org/10.16965/ijar.2016.219.

[13] Bankoglu EE, Arnold C, Hering I, Hankir M, Seyfried F, Stopper H. Decreased chromosomal damage in lymphocytes of obese patients after bariatric surgery. Sci Rep [Internet] 2018;8(1):6e13. https://doi.org/10.1038/s41598-018-29581-6.

[14] Franzke B, Schwingshackl L, Wagner KH. Chromosomal damage measured by the cytokinesis block micronucleus cytome assay in diabetes and obesity - a systematic review and meta-analysis. Mutat Res - Rev Mutat Res [Internet] 2020;786:108343. https://doi.org/10.1016/j.mrrev.2020.108343.

[15] Andreassi MG, Barale R, Iozzo P, Picano E. The association of micronucleus frequency with obesity, diabetes and cardiovascular disease. Mutagenesis 2011;26(1):77e83. https:// doi.org/10.1093/mutage/geq077.

[16] Deo P, Fenech M, Dhillon VS. Mutation Research/Reviews in Mutation Research Association between glycation biomarkers , hyperglycemia , and micronucleus frequency : a meta -analysis. Mutat Res Mutat Res [Internet] 2021;787: 108369. https://doi.org/10.1016/j.mrrev.2021.108369.

[17] Wagner KH, Schwingshackl L, Draxler A, Franzke B. Impact of dietary and lifestyle interventions in elderly or people diagnosed with diabetes, metabolic disorders, cardiovascular disease, cancer and micronutrient deficiency on micronuclei frequency e a systematic review and meta-analysis. Mutat Res - Rev Mutat Res [Internet] 2021;787:108367. https:// doi.org/10.1016/j.mrrev.2021.108367.

[18] Grindel A, Brath H, Nersesyan A, Knasmueller S, Wagner KH. Association of genomic instability with HbA1c levels and medication in diabetic patients. Sci Rep [Internet] 2017;7:1e9. https://doi.org/10.1038/srep41985.

[19] Toljic M, Egic A, Munjas J, Karadzov Orlic N, Milovanovic Z, Radenkovic A, et al. Increased oxidative stress and cytokinesis-block micronucleus cytome assay parameters in pregnant women with gestational diabetes mellitus and gestational arterial hypertension. Reprod Toxicol [Internet] 2017;71:55e62. https://doi.org/10.1016/j.reprotox.2017.04.002.

[20] Da Silva J, Garcia ALH, Matzenbacher CA, Dalberto D, de Souza MR, Rohr P, et al. Micronucleus assay in lymphocytes for human biomonitoring and clinical studies. Biomarkers in Toxicology 2022:1e24. https://doi.org/10.1007/978-3-030-87225- 0_40-1.

[21] Guo X, Dai X, Ni J, Cao N, Yang G, Xue J, et al. High concentration of sugars is genotoxic to folate-deficient cells. Mutat Res - Fundam Mol Mech Mutagen [Internet] 2019:814. https:// doi.org/10.1016/j.mrfmmm.2019.01.003 (January):15e22.

[22] Fenech M, Knasmueller S, Bolognesi C, Holland N, Bonassi S, Kirsch-Volders M. Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humans. Mutat Res - Rev Mutat Res [Internet] 2020;786: 108342. https://doi.org/10.1016/j.mrrev.2020.108342.